Clorox (NYSE:CLX) PT Lowered to $136.00 at Barclays

Clorox (NYSE:CLX) had its price objective lowered by Barclays from $148.00 to $136.00 in a research note released on Wednesday morning, Benzinga reports. The brokerage currently has an underweight rating on the stock.

Other equities research analysts also recently issued research reports about the company. Citigroup reaffirmed a neutral rating and set a $165.00 price objective (down previously from $170.00) on shares of Clorox in a research report on Tuesday, April 2nd. UBS Group raised their price objective on Clorox from $145.00 to $170.00 and gave the company a neutral rating in a research report on Friday, February 2nd. The Goldman Sachs Group assumed coverage on Clorox in a research report on Friday, March 1st. They set a sell rating and a $140.00 price objective on the stock. Morgan Stanley reaffirmed an equal weight rating and set a $160.00 price objective on shares of Clorox in a research report on Tuesday, March 26th. Finally, Jefferies Financial Group raised Clorox from an underperform rating to a hold rating and set a $145.00 price objective on the stock in a research report on Tuesday, March 26th. Four analysts have rated the stock with a sell rating and twelve have issued a hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of Hold and a consensus price target of $149.13.

Clorox Price Performance

CLX opened at $141.98 on Wednesday. Clorox has a 12-month low of $114.68 and a 12-month high of $178.21. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37. The business’s fifty day simple moving average is $151.19 and its 200-day simple moving average is $141.36. The company has a market capitalization of $17.62 billion, a price-to-earnings ratio of 225.37, a PEG ratio of 2.25 and a beta of 0.43.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, February 1st. The company reported $2.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $1.08. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The business had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.80 billion. During the same quarter in the prior year, the company earned $0.98 EPS. The business’s revenue was up 16.0% compared to the same quarter last year. On average, equities research analysts anticipate that Clorox will post 5.52 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be given a dividend of $1.20 per share. This represents a $4.80 annualized dividend and a yield of 3.38%. The ex-dividend date is Tuesday, April 23rd. Clorox’s dividend payout ratio is currently 761.92%.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Tyler Stone Wealth Management purchased a new position in Clorox during the second quarter valued at approximately $25,000. O Dell Group LLC purchased a new position in Clorox during the fourth quarter valued at approximately $28,000. Strategic Investment Solutions Inc. IL purchased a new position in Clorox during the first quarter valued at approximately $31,000. Northwest Financial Advisors purchased a new position in Clorox during the fourth quarter valued at approximately $29,000. Finally, Core Wealth Advisors Inc. purchased a new position in Clorox during the fourth quarter valued at approximately $29,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.